Francis Chu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Francis Chu has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Jennifer J. Fowler
Division of Global Migration Health, National Center for Emerging Zoonotic and Infectious Diseases, Centers for Disease Control and Prevention , Atlanta, Georgia
2 shared publications Abbi Berg
Disease Control and Forensic Pathology Section, North Dakota Department of Health and Human Services , Bismarck, North Dakota
1 shared publication- Adria D. Mathis
Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention , Atlanta, Georgia
1 shared publication - Alida M. Gertz
Division of Global Migration Health, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
1 shared publication Amanda Metz
Division of Disease Control and Public Health Response, Colorado Department of Public Health and Environment , Denver, Colorado
1 shared publication- Andrew Abbott
Division of Parasitic Diseases and Malaria Centers for Disease Control and Prevention Atlanta Georgia USA
1 shared publication
Latest Publications
- 27 February 2026
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 234 (2) , e254-e262
Multiple Measles Transmission Events Associated With a Single Traveler Arriving in the United States, May 2025
Background: Travelers who fly on commercial aircraft while infectious with measles are reported to the US Centers for Disease Control and Prevention (CDC) by health departments. CDC contacts airlines to collect information on potentially exposed travelers. Traveler locating information is shared with health departments to facilitate aircraft contact investigations. In May 2025, CDC was notified of a traveler who flew from Europe to Colorado while infectious with measles, transited through Denver International Airport, then flew from Colorado to North Dakota. This report describes details of the subsequent contact investigations, environmental assessment, and laboratory testing results. Methods: CDC laboratories conducted testing on a majority of case samples. Data from the CDC laboratory, CDC's Port Health Activity Reporting System, and health department investigations were analyzed to describe the index case, contacts, test results, and travel details. Flight records and visual inspection were used to describe relative locations of index and secondary case-patients at Denver International Airport. Results: The index case was in an unvaccinated adult. Aircraft contact investigations identified 135 exposed domestic travelers. Fifteen secondary cases were identified among people exposed during the international (5) and domestic (3) flights and at the airport (7). Two tertiary case-patients were also identified. Five of the secondary case-patients had at least 1 documented prior measles vaccination. Conclusions: Measles transmission may occur during travel. Measles vaccination is recommended prior to international travel for all travelers aged 6 months or older. Travelers with fever and other overt signs of transmissible illness, such as coughing or malaise, should be strongly encouraged to delay travel while symptomatic.
- 27 February 2026
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 234 (2) , e254-e262
Multiple Measles Transmission Events Associated With a Single Traveler Arriving in the United States, May 2025
Background: Travelers who fly on commercial aircraft while infectious with measles are reported to the US Centers for Disease Control and Prevention (CDC) by health departments. CDC contacts airlines to collect information on potentially exposed travelers. Traveler locating information is shared with health departments to facilitate aircraft contact investigations. In May 2025, CDC was notified of a traveler who flew from Europe to Colorado while infectious with measles, transited through Denver International Airport, then flew from Colorado to North Dakota. This report describes details of the subsequent contact investigations, environmental assessment, and laboratory testing results. Methods: CDC laboratories conducted testing on a majority of case samples. Data from the CDC laboratory, CDC's Port Health Activity Reporting System, and health department investigations were analyzed to describe the index case, contacts, test results, and travel details. Flight records and visual inspection were used to describe relative locations of index and secondary case-patients at Denver International Airport. Results: The index case was in an unvaccinated adult. Aircraft contact investigations identified 135 exposed domestic travelers. Fifteen secondary cases were identified among people exposed during the international (5) and domestic (3) flights and at the airport (7). Two tertiary case-patients were also identified. Five of the secondary case-patients had at least 1 documented prior measles vaccination. Conclusions: Measles transmission may occur during travel. Measles vaccination is recommended prior to international travel for all travelers aged 6 months or older. Travelers with fever and other overt signs of transmissible illness, such as coughing or malaise, should be strongly encouraged to delay travel while symptomatic.
- 1 September 2025
- Published by Wiley in Zoonoses and Public Health
- Vol. 72 (8) , 706-712
Country‐Level Canine Leishmaniosis Risk: A Literature Review, 2019–2023
Aims: Dogs are the primary reservoir for Leishmania infantum , a zoonotic, vector‐borne pathogen that causes severe disease in people and dogs. International movement of dogs represents a risk for the introduction of L. infantum into nonendemic countries. Knowing the Leishmania status of the countries a dog has visited allows veterinary and public health professionals to more accurately assess the dog's leishmaniosis risk and take appropriate public health action. The aim of this review was to create a centralised source of information on leishmaniosis risk at the country level to support such assessments. Methods: We reviewed literature and reports published from 2019 to 2023 relating to canine leishmaniosis, L. infantum , and the distribution of sandflies. We developed a scoring system and assigned a risk category to each country, ranging from ‘no evidence of risk’ to ‘high risk’. Results: We scored 91 countries as moderate or high risk, 107 as low risk or no evidence of risk and 44 had no data available. Among the countries scored, data availability was often limited. Conclusions: This review represents a valuable centralised source of information on canine leishmaniosis risk to support public health assessments. Assessments would benefit from improved surveillance and reporting, especially systematic serosurveillance in dogs and inclusion of Leishmania species information in reports of human disease.
- 1 September 2025
- Published by Wiley in Zoonoses and Public Health
- Vol. 72 (8) , 706-712
Country‐Level Canine Leishmaniosis Risk: A Literature Review, 2019–2023
Aims: Dogs are the primary reservoir for Leishmania infantum , a zoonotic, vector‐borne pathogen that causes severe disease in people and dogs. International movement of dogs represents a risk for the introduction of L. infantum into nonendemic countries. Knowing the Leishmania status of the countries a dog has visited allows veterinary and public health professionals to more accurately assess the dog's leishmaniosis risk and take appropriate public health action. The aim of this review was to create a centralised source of information on leishmaniosis risk at the country level to support such assessments. Methods: We reviewed literature and reports published from 2019 to 2023 relating to canine leishmaniosis, L. infantum , and the distribution of sandflies. We developed a scoring system and assigned a risk category to each country, ranging from ‘no evidence of risk’ to ‘high risk’. Results: We scored 91 countries as moderate or high risk, 107 as low risk or no evidence of risk and 44 had no data available. Among the countries scored, data availability was often limited. Conclusions: This review represents a valuable centralised source of information on canine leishmaniosis risk to support public health assessments. Assessments would benefit from improved surveillance and reporting, especially systematic serosurveillance in dogs and inclusion of Leishmania species information in reports of human disease.